Singapore markets closed

Chugai Pharmaceutical Co., Ltd. (4519.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
4,985.00-109.00 (-2.14%)
At close: 03:15PM JST
Currency in JPY

Valuation measures4

Market cap (intra-day) 8.38T
Enterprise value 7.62T
Trailing P/E 25.68
Forward P/E 23.87
PEG ratio (5-yr expected) 7.24
Price/sales (ttm)8.09
Price/book (mrq)5.10
Enterprise value/revenue 7.35
Enterprise value/EBITDA 17.15

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 340.80%
S&P500 52-week change 325.77%
52-week high 36,697.00
52-week low 33,522.00
50-day moving average 35,661.78
200-day moving average 35,060.44

Share statistics

Avg vol (3-month) 32.53M
Avg vol (10-day) 32.88M
Shares outstanding 51.65B
Implied shares outstanding 61.74B
Float 8639.35M
% held by insiders 159.91%
% held by institutions 118.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 482
Forward annual dividend yield 41.61%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 31.57%
5-year average dividend yield 41.70
Payout ratio 440.33%
Dividend date 3N/A
Ex-dividend date 427 Jun 2024
Last split factor 23:1
Last split date 329 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 31.50%
Operating margin (ttm)42.15%

Management effectiveness

Return on assets (ttm)15.01%
Return on equity (ttm)21.20%

Income statement

Revenue (ttm)1.04T
Revenue per share (ttm)629.73
Quarterly revenue growth (yoy)-24.10%
Gross profit (ttm)N/A
EBITDA 467.56B
Net income avi to common (ttm)326.37B
Diluted EPS (ttm)198.16
Quarterly earnings growth (yoy)1.20%

Balance sheet

Total cash (mrq)764.57B
Total cash per share (mrq)464.67
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.53
Book value per share (mrq)997.97

Cash flow statement

Operating cash flow (ttm)383.09B
Levered free cash flow (ttm)287.75B